ATE98490T1 - Arzneimittel, das einen pharmazeutisch geeigneten traeger sowie die verbindung der struktur (7- alpha, 17-alpha)-17-hydroxy-7-methyl-19-nor-17pregn-5(10)-ene-20-yne-3-one enthaelt. - Google Patents

Arzneimittel, das einen pharmazeutisch geeigneten traeger sowie die verbindung der struktur (7- alpha, 17-alpha)-17-hydroxy-7-methyl-19-nor-17pregn-5(10)-ene-20-yne-3-one enthaelt.

Info

Publication number
ATE98490T1
ATE98490T1 AT90200574T AT90200574T ATE98490T1 AT E98490 T1 ATE98490 T1 AT E98490T1 AT 90200574 T AT90200574 T AT 90200574T AT 90200574 T AT90200574 T AT 90200574T AT E98490 T1 ATE98490 T1 AT E98490T1
Authority
AT
Austria
Prior art keywords
alpha
compound
hydroxy
methyl
17pregn
Prior art date
Application number
AT90200574T
Other languages
English (en)
Inventor
Doornum E M Van
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19854317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE98490(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of ATE98490T1 publication Critical patent/ATE98490T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90200574T 1989-03-18 1990-03-12 Arzneimittel, das einen pharmazeutisch geeigneten traeger sowie die verbindung der struktur (7- alpha, 17-alpha)-17-hydroxy-7-methyl-19-nor-17pregn-5(10)-ene-20-yne-3-one enthaelt. ATE98490T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8900673 1989-03-18

Publications (1)

Publication Number Publication Date
ATE98490T1 true ATE98490T1 (de) 1994-01-15

Family

ID=19854317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90200574T ATE98490T1 (de) 1989-03-18 1990-03-12 Arzneimittel, das einen pharmazeutisch geeigneten traeger sowie die verbindung der struktur (7- alpha, 17-alpha)-17-hydroxy-7-methyl-19-nor-17pregn-5(10)-ene-20-yne-3-one enthaelt.

Country Status (16)

Country Link
US (1) US5037817A (de)
EP (1) EP0389035B1 (de)
JP (2) JP3139709B2 (de)
KR (1) KR0183401B1 (de)
AT (1) ATE98490T1 (de)
AU (1) AU625083B2 (de)
CA (1) CA2011452C (de)
DE (1) DE69005165T2 (de)
DK (1) DK0389035T3 (de)
ES (1) ES2062292T3 (de)
FI (1) FI94865C (de)
IE (1) IE63051B1 (de)
MX (1) MX9203787A (de)
NZ (1) NZ232946A (de)
PT (1) PT93488B (de)
ZA (1) ZA901674B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE180669T1 (de) * 1993-03-05 1999-06-15 Akzo Nobel Nv Verwendung von pregnanderivaten zur behandlung von tumoren
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
IL123984A (en) 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
ATE239032T1 (de) * 1998-10-16 2003-05-15 Akzo Nobel Nv (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17- pregn-5-(10)-en-20-yn-3-on als reine verbindung
AU779138B2 (en) * 1999-03-18 2005-01-06 Genelabs Technologies, Inc. DHEA composition and method
US7045513B1 (en) 1999-03-18 2006-05-16 Genelabs Technologies, Inc. DHEA composition and method
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
DE60220699T2 (de) * 2001-10-18 2008-03-06 Norton Healthcare Ltd. Tibolonformulierungen
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
KR20040073572A (ko) * 2002-01-22 2004-08-19 악조 노벨 엔.브이. 내인성 에스트로겐의 합성을 예방하는 약물의 투여와관련된 호소 증상의 치료에서의 티볼론
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
CN1324041C (zh) * 2003-04-01 2007-07-04 上海迪赛诺医药科技开发有限公司 替勃龙晶型i的制备方法
PL1499278T3 (pl) * 2003-05-23 2005-09-30 Msd Oss Bv Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon
WO2006125453A1 (en) * 2005-05-23 2006-11-30 Newchem S.P.A. Process for the preparation of pure crystalline tibolone
EP1821571A1 (de) * 2006-02-15 2007-08-22 Oticon A/S Schleifenantenne für In-dem-Ohr-Hörereinrichtung
ITMI20130120A1 (it) * 2013-01-25 2014-07-26 Ind Chimica Srl Processo per la preparazione in forma cristallina di tibolone, (7alfa,17alfa)-17-idrossi-7-metil-19-norpregn-5(10)-en-20-in-3-one
US10736907B2 (en) 2016-05-04 2020-08-11 Novalon S.A. Use of sugar-alcohols in tibolone compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (de) * 1964-06-16
US4933168A (en) * 1975-05-27 1990-06-12 Syntex Pharmaceuticals International Limited Stable, crystalline flunisolide
US4273710A (en) * 1979-05-21 1981-06-16 Syntex Corporation Process for preparing flunisolide
US4447426A (en) * 1982-01-18 1984-05-08 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4391755A (en) * 1982-01-18 1983-07-05 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators

Also Published As

Publication number Publication date
IE63051B1 (en) 1995-03-22
HK1002019A1 (en) 1998-07-24
IE900709L (en) 1990-09-18
DE69005165D1 (de) 1994-01-27
JPH0347195A (ja) 1991-02-28
FI94865C (fi) 1995-11-10
FI94865B (fi) 1995-07-31
JP2001139473A (ja) 2001-05-22
KR0183401B1 (ko) 1999-05-01
JP3139709B2 (ja) 2001-03-05
MX9203787A (es) 1992-07-01
AU5139490A (en) 1990-09-20
ZA901674B (en) 1990-12-28
ES2062292T3 (es) 1994-12-16
CA2011452C (en) 1999-05-25
KR900013950A (ko) 1990-10-22
EP0389035A1 (de) 1990-09-26
DE69005165T2 (de) 1994-05-05
PT93488A (pt) 1990-11-07
US5037817A (en) 1991-08-06
FI901328A0 (fi) 1990-03-16
DK0389035T3 (da) 1994-02-14
AU625083B2 (en) 1992-07-02
PT93488B (pt) 1996-02-29
CA2011452A1 (en) 1990-09-18
EP0389035B1 (de) 1993-12-15
NZ232946A (en) 1991-08-27

Similar Documents

Publication Publication Date Title
ATE98490T1 (de) Arzneimittel, das einen pharmazeutisch geeigneten traeger sowie die verbindung der struktur (7- alpha, 17-alpha)-17-hydroxy-7-methyl-19-nor-17pregn-5(10)-ene-20-yne-3-one enthaelt.
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
BR1100860A (pt) Composto, droga antiinflamatória, composição farmacêutica, epìmero r e epìmero s do composto
DE3770730D1 (de) Antikrebstherapie und zytotoxische arzneimittel fuer deren implementation.
DE3750431D1 (de) Stabilisiertes Arzneimittel und dessen Herstellung.
IE862554L (en) Pharmaceutical compositions
CA2116238A1 (en) Oral 1 .alpha.-hydroxyprevitamin d
IT1224795B (it) Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
CA2068871A1 (en) Non-glycosylated fgf-4 and compositions containing the same
DE3887014D1 (de) Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.
DE69006654D1 (de) Einen Zink-Komplex enthaltende Arzneimittel.
NO166281C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,1-disubstituerte cyklopropanderivater.
NZ234369A (en) 6-(naphthalenylethyl)-4-hydroxy-pyran-2-one derivatives and the 3,5-dihydroxyheptanoates; pharmaceutical compositions
IT8805224A0 (it) Composizione a base di poliesteri per la liberazione controllata di sostanze medicamentose.
ITRM920535A0 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
DE3786927D1 (de) Antithrombotische arzneimittel und deren herstellung.
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
FR2685204B1 (fr) Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
IT1244562B (it) Agente per la prevenzione ed il trattamento dell'opacita' del cristallino.
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
GB2185478B (en) Novel e-valerolactam, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use
IT8719390A0 (it) Composizione farmaceutica per la prevenzione e il trattamento dell'aterosclerosi.
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
ITRM910432A0 (it) Dispositivo per l'applicazione endo ed esoretale di sostanze farmacologoche, medicamentose e rinfrescanti.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time